Logos Global Management LP
- SEC CIK
- 0001792126
- 最新申報
- 2026/8/14
2024 年第 2 季持倉
持倉截至 2024/6/30，2024/8/27 申報。只含多頭部位，變化是跟 2024 年第 1 季比股數。
- 持股檔數
- 51
- 較 2024 年第 1 季 +1
- 總值
- $8.68 億
- 較 2024 年第 1 季 −$8,236 萬 (−8.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| IDYAIDEAYA Biosciences, Inc. | COM | 1,700,000 | $5,969 萬 | 6.9% | +200,000+13.3% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 135,000 | $5,806 萬 | 6.7% | +135,000 | 新進 | 歷史 |
| MRUSMerus N.V. | COM | 850,000 | $5,029 萬 | 5.8% | +850,000 | 新進 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 1,200,000 | $4,657 萬 | 5.4% | +1,200,000 | 新進 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,100,000 | $4,320 萬 | 5.0% | +379,942+52.8% | 加碼 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 925,000 | $4,169 萬 | 4.8% | +925,000 | 新進 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 5,150,000 | $3,523 萬 | 4.1% | −661,436−11.4% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,208,875 | $3,472 萬 | 4.0% | −1,175,000−26.8% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 950,000 | $3,437 萬 | 4.0% | +375,000+65.2% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 750,000 | $3,298 萬 | 3.8% | +750,000 | 新進 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 750,000 | $3,142 萬 | 3.6% | +600,000+400.0% | 加碼 | 歷史 |
| XNCRXencor Inc | COM | 1,500,000 | $2,840 萬 | 3.3% | +850,000+130.8% | 加碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,476,061 | $2,805 萬 | 3.2% | 00.0% | 不變 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 150,000 | $2,370 萬 | 2.7% | −250,000−62.5% | 減碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 800,000 | $1,877 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 5,032,501 | $1,686 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| ANNXAnnexon, Inc. | COM | 3,300,000 | $1,617 萬 | 1.9% | +250,000+8.2% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 400,000 | $1,534 萬 | 1.8% | −400,000−50.0% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 575,000 | $1,518 萬 | 1.7% | −1,200,000−67.6% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 195,000 | $1,479 萬 | 1.7% | +195,000 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 375,000 | $1,462 萬 | 1.7% | +375,000 | 新進 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 300,000 | $1,430 萬 | 1.6% | +300,000 | 新進 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 1,050,000 | $1,419 萬 | 1.6% | +1,050,000 | 新進 | 歷史 |
| ERASErasca, Inc. | COM | 5,900,000 | $1,392 萬 | 1.6% | +5,900,000 | 新進 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 595,000 | $1,391 萬 | 1.6% | −979,220−62.2% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 575,000 | $1,352 萬 | 1.6% | +325,000+130.0% | 加碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 1,200,000 | $1,132 萬 | 1.3% | +400,000+50.0% | 加碼 | 歷史 |
| Cybin Ord23256X100 | COM | 40,000,000 | $1,084 萬 | 1.2% | 00.0% | 不變 | – |
| SKYESkye Bioscience, Inc. | COM NEW | 1,301,518 | $1,043 萬 | 1.2% | +1,301,518 | 新進 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 3,850,000 | $1,040 萬 | 1.2% | +2,850,000+285.0% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 265,000 | $935.2 萬 | 1.1% | −1,465,000−84.7% | 減碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 250,000 | $867.8 萬 | 1.0% | +250,000 | 新進 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,300,000 | $847.6 萬 | 1.0% | +1,300,000 | 新進 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 2,800,000 | $834.4 萬 | 1.0% | +600,000+27.3% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 350,000 | $753.5 萬 | 0.9% | −950,000−73.1% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,159,030 | $700.1 萬 | 0.8% | +901,050+349.3% | 加碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 539,079 | $672.2 萬 | 0.8% | +539,079 | 新進 | 歷史 |
| LCTXLineage Cell Therapeutics, Inc. | COM | 4,700,000 | $468.7 萬 | 0.5% | −1,550,000−24.8% | 減碼 | 歷史 |
| ATYRaTYR PHARMA INC | COM NEW | 3,000,000 | $468.0 萬 | 0.5% | −100,000−3.2% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 500,000 | $455.0 萬 | 0.5% | −744,960−59.8% | 減碼 | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 208,910 | $437.3 萬 | 0.5% | +208,910 | 新進 | 歷史 |
| NXTCNextCure, Inc. | COM | 2,500,000 | $397.5 萬 | 0.5% | +575,000+29.9% | 加碼 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 300,000 | $294.9 萬 | 0.3% | −82,345−21.5% | 減碼 | 歷史 |
| ALLKAllakos Inc. | COM | 2,900,000 | $290.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM NEW | 416,666 | $285.8 萬 | 0.3% | −1,083,333−72.2% | 減碼 | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 600,000 | $266.2 萬 | 0.3% | −750,000−55.6% | 減碼 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM NEW | 90,000 | $243.1 萬 | 0.3% | +90,000 | 新進 | 歷史 |
| UNCYUnicycive Therapeutics, Inc. | COM | 3,469,927 | $173.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IOBTIO Biotech, Inc. | COM | 493,827 | $57.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BOLDBoundless Bio, Inc. | COM | 117,806 | $43.3 萬 | <0.1% | −82,194−41.1% | 減碼 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 66,666 | $1.07 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $1.85 億 | – |
| SRPTSarepta Therapeutics, Inc. | COM | – | $7,900 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $7,672 萬 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | – | $1,767 萬 |
| FULCFulcrum Therapeutics, Inc. | COM | – | $930.0 萬 |
| ANNXAnnexon, Inc. | COM | – | $735.0 萬 |
2024 年第 1 季之後清倉（15 檔）
2024 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 1 季股數 | 2024 年第 1 季市值 | 2024 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| IMCRImmunocore Holdings plc | ADS | 900,000 | $5,850 萬 | 6.2% | 歷史 |
| GERNGeron Corp | COM | 9,000,000 | $2,970 萬 | 3.1% | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 650,000 | $2,728 萬 | 2.9% | 歷史 |
| CGONCG Oncology, Inc. | COM | 300,000 | $1,317 萬 | 1.4% | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 500,000 | $1,242 萬 | 1.3% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 700,000 | $1,226 萬 | 1.3% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 700,000 | $1,193 萬 | 1.3% | 歷史 |
| IMTXImmatics N.V. | SHS | 1,000,000 | $1,051 萬 | 1.1% | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 150,000 | $915.3 萬 | 1.0% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 350,000 | $833.0 萬 | 0.9% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 100,000 | $701.1 萬 | 0.7% | 歷史 |
| KURAKura Oncology, Inc. | COM | 300,000 | $639.9 萬 | 0.7% | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 99,208 | $227.2 萬 | 0.2% | 歷史 |
| IMUXImmunic, Inc. | COM | 421,184 | $55.6 萬 | 0.1% | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM NEW | 39,500 | $10.5 萬 | <0.1% | 歷史 |